The present disclosure is directed to novel carbocyclic compounds of formula (I) and pharmaceutically acceptable salts thereof wherein R1 R2 R3 R4 R5 R6 Ra Rb n m and p are as defined herein which are active as modulators of retinoid related orphan receptor gamma t (RORt). These compounds prevent inhibit or suppress the action of RORt and are therefore useful in the treatment of RORt mediated diseases disorders syndromes or conditions such as e.g. pain inflammation COPD asthma rheumatoid arthritis colitis multiple sclerosis psoriasis neurodegenerative diseases and cancer.
